Sox2 regulatory region 2 sequence works as a DNA nuclear targeting sequence enhancing the efficiency of an exogenous gene expression in ES cells

Biochemical and Biophysical Research Communications

Volumn 400, Issue 4, 2010, Pages 554-558

  Funabashi, Hisakage ^a   Takatsu, Makoto ^a   Saito, Mikako ^a   Matsuoka, Hideaki ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

DNA nuclear targeting sequence; Embryonic stem cells; Femtoinjection; Oct3 4; Sox2; Transfection

Indexed keywords

DNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ARTICLE; BASE PAIRING; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSFECTION; INSULINOMA; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

ANIMALS; BASE SEQUENCE; CELL NUCLEUS; CELLS, CULTURED; DNA; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; MICE; REGULATORY SEQUENCES, NUCLEIC ACID; SIMIAN VIRUS 40; SOXB1 TRANSCRIPTION FACTORS;

SIMIAN VIRUS 40;

EID: 77957265343     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.098     Document Type: Article

References (27)

1. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78:7634-7638.
2. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
3. Niwa H. How is pluripotency determined and maintained?. Development 2007, 134:635-646.
4. Chai C., Leong K.W. Biomaterials approach to expand and direct differentiation of stem cells. Mol. Ther. 2007, 15:467-480.
5. Lerou P.H., Daley G.Q. Therapeutic potential of embryonic stem cells. Blood Rev. 2005, 19:321-331.
6. Zwaka T.P., Thomson J.A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 2003, 21:319-321.
7. Ko B.S., Chang T.C., Shyue S.K., Chen Y.C., Liou J.Y. An efficient transfection method for mouse embryonic stem cells. Gene Ther. 2009, 16:154-158.
8. Lam A.P., Dean D.A. Progress and prospects: nuclear import of nonviral vectors. Gene Ther. 2010, 17:439-447.
9. Dean D.A. Import of plasmid DNA into the nucleus is sequence specific. Exp. Cell Res. 1997, 230:293-302.
10. Dean D.A., Dean B.S., Muller S., Smith L.C. Sequence requirements for plasmid nuclear import. Exp. Cell Res. 1999, 253:713-722.
11. Dean D.A., Byrd J.N., Dean B.S. Nuclear targeting of plasmid DNA in human corneal cells. Curr. Eye Res. 1999, 19:66-75.
12. Vacik J., Dean B.S., Zimmer W.E., Dean D.A. Cell-specific nuclear import of plasmid DNA. Gene Ther. 1999, 6:1006-1014.
13. Miller A.M., Dean D.A. Cell-specific nuclear import of plasmid DNA in smooth muscle requires tissue-specific transcription factors and DNA sequences. Gene Ther. 2008, 15:1107-1115.
14. Miller A.M., Munkonge F.M., Alton E.D., Dean D.A. Identification of protein cofactors necessary for sequence-specific plasmid DNA nuclear import. Mol. Ther. 2009, 17:1897-1903.
15. Miller A.M., Dean D.A. Tissue-specific and transcription factor-mediated nuclear entry of DNA. Adv. Drug Deliv. Rev. 2009, 61:603-613.
16. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., Ko M.S., Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 2007, 9:625-635.
17. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
18. Tomioka M., Nishimoto M., Miyagi S., Katayanagi T., Fukui N., Niwa H., Muramatsu M., Okuda A. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 2002, 30:3202-3213.
19. Matsuoka H., Komazaki T., Mukai Y., Shibusawa M., Akane H., Chaki A., Uetake N., Saito M. High throughput easy microinjection with a single-cell manipulation supporting robot. J. Biotechnol. 2005, 116:185-194.
20. Matsuoka H., Shimoda S., Ozaki M., Mizukami H., Shibusawa M., Yamada Y., Saito M. Semi-quantitative expression and knockdown of a target gene in single-cell mouse embryonic stem cells by high performance microinjection. Biotechnol. Lett. 2007, 29:341-350.
21. Yamada Y., Yamaguchi N., Ozaki M., Shinozaki Y., Saito M., Matsuoka H. An instant cell recognition system using a microfabricated coordinate standard chip useful for combinable cell observation with multiple microscopic apparatuses. Microsc. Microanal. 2008, 14:236-242.
22. Niwa H., Masui S., Chambers I., Smith A.G., Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell Biol. 2002, 22:1526-1536.
23. Miyazaki J., Araki K., Yamato E., Ikegami H., Asano T., Shibasaki Y., Oka Y., Yamamura K. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 1990, 127:126-132.
24. Yasuhara N., Shibazaki N., Tanaka S., Nagai M., Kamikawa Y., Oe S., Asally M., Kamachi Y., Kondoh H., Yoneda Y. Triggering neural differentiation of ES cells by subtype switching of importin-alpha. Nat. Cell Biol. 2007, 9:72-79.
25. Yasuhara N., Oka M., Yoneda Y. The role of the nuclear transport system in cell differentiation. Semin. Cell Dev. Biol. 2009, 20:590-599.
26. Ma H., Liu Q., Diamond S.L., Pierce E.A. Mouse embryonic stem cells efficiently lipofected with nuclear localization peptide result in a high yield of chimeric mice and retain germline transmission potency. Methods 2004, 33:113-120.
27. Yang F., Green J.J., Dinio T., Keung L., Cho S.W., Park H., Langer R., Anderson D.G. Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors. Gene Ther. 2009, 16:533-546.